Effects of Propofol-Induced Anaesthesia on the ST-segment of the ECG
Overview
The purpose of this study is to assess the effect of propofol induced general anaesthesia on the ST-segment of the electrocardiogram. This will be realised by retrospectively analysing the ECG-recordings from adult patients undergoing any treatment at the Catheterisation Laboratory. The ST-segment and other ECG measurements from induction of anaesthesia up to 20 minutes later, will be assessed and compared to the baseline values of the respective segments acquired before injecting propofol. It is essential in this study to exclude any patients burdened with the diagnosis, suspicion or family history of Brugada syndrome.
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Retrospective
- Study Primary Completion Date: April 2022
Interventions
- Other: Observational study
- Retrospective data-analysis
Arms, Groups and Cohorts
- non-Brugada population
- Adult patients who underwent general anaesthesia (with propofol as induction agent) at the catheterisation laboratory of the UZ Brussel
Clinical Trial Outcome Measures
Primary Measures
- ST-segment variations after propofol administration.
- Time Frame: Baseline ECG will be measured before administration of propofol. ECG will be measured in the 20 minutes following administration of propofol
- Determine ST-segment variations in mm (either augmentation or suppression) on the ECG in the 20 minute period after administration of propofol in comparison to the baseline ECG
Secondary Measures
- Additional ECG-segment variations after propofol administration
- Time Frame: Baseline ECG will be measured before administration of propofol. ECG will be measured in the 20 minutes following administration of propofol
- Assess additional ECG-segments measurements in mm and ms from the ECGs recorded. These include Jp- (mm), QRS- (ms), T(p-e)-segments (ms) and the T(p-e)/QT ratio.
Participating in This Clinical Trial
Inclusion Criteria
- Induction of anaesthesia with propofol – Monitored anaesthesia in the CathLab of the Universitair Ziekenhuis Brussel Exclusion Criteria:
- Brugada Syndrome or family history of Brugada syndrome – Paediatric population (age <18) – Patients who did not receive propofol during the procedure – Patients who presented with fever (central core temperature >38,0°C)
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: No
Investigator Details
- Lead Sponsor
- Universitair Ziekenhuis Brussel
- Provider of Information About this Clinical Study
- Sponsor
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.